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Abstract: Eleven compounds:goniomicin A (1), goniomicin B (2), goniomicin C (3), 
goniomicin D (4), tapisoidin (5), goniothalamin (6), 9-deoxygoniopypyrone (7), 
pterodondiol (8), liriodenine (9), benzamide (10) and cinnamic acid (11), were isolated 
from the stem bark of Goniothalamus tapisoides. All compounds were identified by 
spectroscopic analysis and, for known compounds, by comparison with published data. 
Goniothalamin (6) exhibited mild cytotoxic activity towards a colon cancer cell line (HT-29), 
with an IC50value of 64.17 ± 5.60 µM. Goniomicin B (2) give the highest antioxidant 
activity in the DPPH assay among all compounds tested, with an IC50 of 0.207 µM. 
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1. Introduction  
The genus Goniothalamus (Annonaceae) comprises about 160 species of shrubs and trees native to 
tropical and subtropical Asia [1]. Goniothalamus tapisoides Mat Salleh, locally known as “selada” or 
“semukau”, is endemic to Borneo, especially the Southern part of Sarawak. This species is a small tree 
of about 5 m in height and is used by the native folks as an abortifacient and to cure poisonous animal 
bites such as snake, scorpion or insect bites. It is also used to relieve stomachaches [2]. 
In recent years, Goniothalamus species have been receiving considerable attention because of their 
reputation for producing styryl lactones and acetogenins which possessre markable cytotoxic and 
antitumor properties against various human tumor cell lines such as A-549 (lung carcinoma), HL-60 
(promyelocytic leukemia), and SGC-7901 (stomach cancer) [1,3]. Previous studies on the mechanism 
of action of (R)-goniothalamin have shown that it is able to induce apoptosis in MCF-7 (breast cancer) 
and HL-60 human cancer cells [3–6]. 
In our continuous effort to search for new and bioactive compounds from the Malaysian flora [7–10], 
we have embarked on a chemical study of the cytotoxic stem bark extracts of G. tapisoides Mat Salleh. 
To the knowledge of the authors, such a phytochemical study of this planthas never been reported. 
From this study, the eleven compounds shown in Figure 1 were isolated, of which five are new: 
goniomicin A (1), goniomicin B (2), goniomicin C (3), goniomicin D (4) and tapisoidin (5). The 
known compounds are goniothalamin (6), 9-deoxygoniopypyrone (7), pterodondiol (8), liriodenine (9), 
benzamide (10) and cinnamic acid (11). Compounds 1–6 were tested for cytotoxic activity against 
eight cancer cell lines and for antioxidant activity. 
Figure 1. Structure of compounds 1–11. 
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2. Results and Discussion  
2.1. Isolation and Chemistry 
Goniomicin A (1) was obtained as a pale yellowish amorphous powder, ሾߙሿ஽ଶ଺.଻+2.5° (c 0.0239, 
MeOH). A molecular formula of C13H14O3was deduced from the ESI-TOF-MS spectrum, that showed 
a strong fragmentation peak at m/z199.1020 [M−H−H2O]− (calc. 199.0759) corresponding to the loss 
of a water molecule, thus indicating the presence of a hydroxyl group. This is in agreement with  
the 13C-NMR and HSQC spectra which confirmed the presence of thirteen carbons. The UV spectrum 
(λmax 206 and 251 nm) suggested the presence of a phenyl group [11]. The IR spectrum showed 
absorptions of hydroxyl (νmax 3344 cm−1) and carbonyl (νmax 1668 cm−1) functionalities.  
The 1H-NMR spectrum (Table 1) revealed downfield signals at δ 5.96, δ 6.12, δ 6.20 and δ 6.59 
assignable to H-2, H-3, H-6 and H-7, respectively, thereforeindicating the presence of four olefinic 
protons. The coupling constant between H-2 and H-3 is 11.5 Hz which is indicative of a cis- 
configuration [11]. On the other hand, H-6 and H-7 assumed a trans-configuration, with a J coupling 
value of 16.0 Hz. 
Table 1. 1H-NMR, 13C-NMR and HMBC (400 MHz) data of 1 and 2(CDCl3, δ in ppm, J in Hz). 
Atom  1 2 
No. δ 13C δ 1H HMBC δ 13C δ 1H HMBC 
1 169.6 -  166.8 -  
2 125.3 5.96 (1H, d, J = 11.5) C-1, C-3, C-4 123.9 5.94 (1H, d, J = 15.6) C-1, C-4 
3 140.6 
6.12 (1H, dt,  
J = 8.6, 11.5)  
C-1, C-4, C-5 144.7 7.00 (1H, m) C-1, C-4 
4α 
4β 36.6 
2.76 (1H, m) 
2.81 (1H, m)  
C-2, C-3, C-5, 
C-6 
40.2 2.54 (2H, m) 
C-2, C-3, C-5, 
C-6 
5 71.5 4.41 (1H, m)  C-3, C-4, C-7 71.6 
4.44 (1H, dd,  
J = 6.6, 13.3) 
C-3, C-7 
6 131.9 
6.20 (1H, dd,  
J = 16.0, 6.7)  
C-4, C-5, C-8 130.9 
6.22(1H, dd,  
J = 16.0, 6.6) 
C-5, C-8 
7 129.9 6.59 (1H, d, J = 16.0) 
C-5, C-8, C-9, 
C-13 
131.3 6.61 (1H, d, J = 16.0) 
C-5, C-9,  
C-13 
8 136.7 -  136.3 -  
9,13 126.5 7.19–7.34 (m)  126.5 7.24–7.38 (m)  
10,12 128.6 7.19–7.34 (m) C-8 128.6 7.24–7.38 (m) C-8 
11 127.6 7.19–7.34 (m)  128.0 7.24–7.38 (m)  
1-OH - 6.27 (OH, br s) C-2 - -  
5-OH - 6.57 (OH, br s) C-5 - -  
1-
OMe 
- -  51.6 3.72 (3H, s) C-1 
The 13C-NMR spectrum (Table 1) showed the presence of one methylene, ten methines, one 
quaternary carbon and one carbonyl. The carbonyl carbon (C-1) resonated at δ 169.6. The adjacent C-2 
and C-3 carbons gave signals at δ 125.3 and δ 140.6, respectively. The downfield shift of C-3 is due to 
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the resonance effect of the α-β unsaturated carboxylic acid moiety [11]. In addition, a deshielded 
oxymethine signal attributable to C-5 was apparent at δ 71.5. 
The 1H-1H COSY spectrum and 1H-13C HSQC spectrum confirmed the connectivities between  
C-2–C-3–C-4–C-5–C-6–C-7. The HMBC correlations indicated the linkage of the C-2 to carbonyl C-1 
and C-7 to the phenyl ring C-8 (Table 1). Thus, the structure of goniomicin A (1) was elucidated as 
illustrated in Figure 1. The occurrence of compound 1 in Goniothalamus tapisoides is of interest since 
it may be a precursor of goniothalamin (6). A plausible biogenetic pathway for the formation of 6 from 
1 is illustrated in Scheme 1. Compound 1 undergoes a dehydration and cyclization reaction to form 6. 
Scheme 1. Dehydration and cyclization of 1 to 6. 
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Goniomicin B (2) was isolated as pale yellowish amorphous powder,  ሾߙሿ஽ଶ଺.ଶ  +2.4° (c 0.0082, 
CH2Cl2). Its molecular formula, C14H16O3, was deduced from the ESI-TOF-MS (m/z 231.1201,  
[M−H]−; calc. 231.1021). The IR spectrum showed a strong absorptionfora conjugated carbonyl group 
of an ester at 1718 cm−1, while the UV absorption bands at 207 and 251 nmindicated the presence of a 
phenyl group [11]. 
The 1H-NMR and 13C-NMR spectra of 1 and 2 (Table 1) are very similar to each other,except for 
the existence of a three proton singlet at δ 3.72 and a methyl carbon at δ 51.6 in the 1H- and 13C-NMR 
spectra, respectively. This observation suggested the presence of an additional methoxyl group,which 
is attached to the C-1 carbonyl group. A noticeable difference was also observed in the coupling 
constant value (15.6 Hz) of protons H-2 and H-3, suggesting a trans-configuration. From the 1H-NMR, 
13C-NMR, 1H–1H COSY, HSQC and HMBC spectra analyses, the complete assignment ofgoniomicin 
B (2) was established. 
Goniomicin C (3) was obtained as pale yellowish amorphous powder,  ሾߙሿ஽ଶଷ.ହ−4.9° (c 0.0122, 
CH2Cl2). The ESI-TOF-MS spectrum gave a prominent peak at m/z 231.1077, [M−H]−;  
(calc. 231.1021), corresponding to the molecular formula C14H16O3. The IR spectrum showed a C=O 
stretching absorption bands at 1731 cm−1 and C-O stretching ones at 1241 and 1090 cm−1. The UV 
absorptions at 206 and 251 nmsuggested the existence of a phenyl group [11]. 
The 1H-NMR spectrumof 3 is relatively similar to that of goniothalamin (6). However, the olefinic 
proton signals of the lactone ring are absent. Instead two methylene proton signals and one oxymethine 
proton signal appeared at δ 2.73 and δ 3.82, corresponding to H2-2 and H-3, respectively. Another 
oxymethine signal, assignable to H-5, appeared at δ 5.20 as a ddd with coupling constants of 11.0,  
6.4 and 3.5 Hz respectively (Table 2). In addition, one singlet corresponding to three protons of a 
methoxyl group was apparent at δ 3.36. The 13C-NMR spectrum showed the expected fourteen 
carbons: one methyl, two methylene, nine methines and two quaternary carbons.The oxymethine 
carbons, C-3 and C-5, resonated at δ 71.4 and δ 76.2, respectively.In the HMBC spectrum (Table 2), 
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the carbonyl carbon (C-1) signal (δ 169.7) correlated with the protons signal at δ 2.73 (H2-2), while the 
carbon at δ 71.4 (C-3) correlated with the proton at δ 5.20 (H-5). Thus it can be deduced that the 
methoxy group is attached to C-3. 
Table 2. 1H-NMR, 13C-NMR and HMBC (400 MHz) data of 3 (CDCl3, δ in ppm, J in Hz). 
Atom 
no.  δ 
13C δ 1H  HMBC  Atom 
no.  δ 
13C δ 1H  HMBC 
1 169.7 -   7 132.5 6.68 (1H, d,  
J = 16.0) 
C-5, C-9,  
C-13 
2 35.7 
2.73 (2H, td,  
J = 4.3, 1.4) 
C-1 8 136.0 -  
3 71.4 3.82 (1H, m)  9,13 126.7 7.24–7.37 (m)  
4α 
4β 33.7 
1.87 (1H, ddd,  
J = 14.8, 11.0, 3.5) 
2.18 (1H, m) 
 
10,12 
11 
128.8 
128.3 
7.24–7.37 (m) 
7.24–7.37 (m) 
 
5 76.2 
5.20 (1H, ddd,  
J = 11.0, 6.4, 3.5) 
C-3 3-OMe 56.3 3.36 (3H, s) C-3 
6 126.6 
6.18 (1H, dd,  
J = 16.0, 6.4) 
C-5,  
C-8 
    
The relative stereochemistry of 3 was established by the NOESY spectrum. H-5α, which is axially 
oriented, correlated with H-4, therefore suggesting that H-4 adopts an α spatial orientation [12]. H-6 
showed correlation to H-5β thus implyingthat H-6 is β oriented.With the aid of the 1H-NMR,  
13C-NMR, 1H-1H COSY, HSQC and HMBC spectra analyses, the full assignment of goniomicin C (3) 
was determined. 
Goniomicin D (4) was crystalisedfrom a solution of hexane-dicholoromethane as white rod crystals 
(mp. 240–243 °C), ሾߙሿ஽ଶଷ.଻ +37.17° (c 0.0191, MeOH). Its molecular formula was determined to be 
C15H18O2N2 by ESI-TOF-MS (m/z281.1278, [M+Na]+; calc. 281.1266). The IR spectrum showed 
absorption peaks of N-H stretching at 3413.15 cm−1 and a C=O group at 1662 cm−1 [11]. The UV 
spectrum revealed maxima at 206 and 252 nm, suggesting the presence of a phenyl group [11].  
The 1H-NMR spectrum showed four methylene signals at δ 2.28/2.64 (H2-2), δ 1.74 (H2-4), δ 
4.13/4.64 (H2-14) and δ 3.82/4.34 (H2-15) (Table 3). The downfield shift of H2-14 and H2-15 were due 
to the neighboring nitrogen and oxygen. The 13C-NMR showed signals corresponding to fifteen 
carbons: four methylenes, nine methines, one quaternary and one carbonyl carbon. The methylene 
carbons C-14 and C-15 resonated downfield at δ 82.9 and δ 58.9, respectively. The carbonyl carbon  
(C-1) gave a peak at δ 168.9. The HMBC spectrum (Figure 1) revealed cross peaks betweenthe 
methylene at δ 4.13/4.64 (H2-14) and C-3 (δ 54.1), C-5 (δ 77.3) and C-15 (δ 58.9). Two methylene 
signals of H2-2 (δ 2.28/2.64) and H2-15 (δ 3.82/4.34) were correlated to the carbonyl C-1. From  
a 1H–1H COSY experiment, the entire sequence C-2–C-3–C-4–C-5–C-6 was identified.Thorough 
analyses of 1D and 2D NMR data analyses allowed the full assignment of all protons and carbons as 
listed in Table 3. 
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Table 3. 1H-NMR, 13C-NMR and HMBC (400 MHz) data of 4 (CDCl3, δ in ppm, J in Hz). 
Atom 
no.  δ 
13C δ 1H  HMBC Atom 
no.  δ 
13C δ 1H  HMBC 
1 168.9 -  9,13 126.6 7.19–7.34 (m)  
2α 
2β 37.2 
2.28 (1H, dd,  
J = 17.6, 7.8) 
2.64 (1H, dd,  
J = 17.6, 5.5) 
C-1, C-3, 
C-4 
C-1 
10,12 
11 
128.7 
128.0 
7.19–7.34 (m) 
7.19–7.34 (m) 
 
3 54.1 2.98 (1H, m)  14α 82.9 4.13 (1H, d, J = 9.2) C-15, C-3, 
C-5 
4 35.6 1.74 (2H, m) C-3, C-5 14β  4.64 (1H, d, J = 9.2) C-3, C-5 
5 77.3 4.17 (1H, m)  15α 58.9 3.82 (1H, d, J = 8.7) C-1, C-3 
6 128.3 
6.20 (1H, dd,  
J = 16.0, 6.0) 
C-5, C-8 15β  4.34 (1H, dd,  
J = 8.7, 2.7) 
 
7 131.3 
6.63 (1H, d,  
J = 16.0) 
C-5, C-9, 
C-13 
N-H - 6.41 (NH, br s)  
8 136.4 -      
The relative stereochemistry of 4 was established with the aid of the NOESY spectrum. H-15α 
which is axially oriented showed a NOESY correlation with H-3, which in turn showed correlation 
with H-5, therefore suggesting that both H-3 and H-5 assume an α-spatial orientation. The structure 
and relative stereochemistry was further confirmed using single-crystal X-ray diffraction analysis 
CCDC 912021 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union 
Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk). An 
ORTEP drawing of 4 is shown in Figure 2.  
Figure 2. HMBC correlations and ORTEP diagram of 4. 
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Tapisoidin (5) was obtained as pale yellowish amorphous powder, ሾߙሿ஽ଶଷ.଼ −25.9° (c 0.0058, 
CH2Cl2). Its molecular formula was determined to be C18H17O4N by ESI-TOF-MS (m/z 334.1074, 
[M+Na]+; calc. 334.1055). The IR spectrum displayed a band at 1715 cm−1 representing the C=O 
group of the molecule. The UV spectrum (λmax 209, 251, 277 and 322 nm) indicated the presence of a 
basic aristolactam alkaloid structure [11]. The 1H-NMR spectrum (Table 4) showed signals for four 
adjacent aromatic protons at δ 8.35 (H-5, dd, J = 7.9, 1.4), δ 7.40 (H-6, m), δ 7.44 (H-7, m) and δ 7.35 
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(H-8, dd, J = 7.9, 1.4). Signals for three methyl groups at δ 3.96, δ 3.89 and δ 4.00 were assigned to the 
methoxyl groups at N-11, C-3 and C-4, respectively. The positions of the methoxyl groups were 
established from the NOESY and HMBC spectra. In the NOESY spectrum, the methyl protons of the 
methoxyl group at C-3 showed correlations with H-2. In the HMBC spectrum, the proton signal at δ 
7.23 (H-2) correlated with the carbons signal at δ 59.7 (3-OCH3) and δ 56.0 (4-OCH3), thereby 
confirmed the assignments of the methoxyl groups. 
Table 4. 1H-NMR, 13C-NMR and HMBC (400 MHz) data of 5 (CDCl3, δ in ppm, J in Hz). 
Atom 
no.  δ 
13C δ1H  HMBC  Atom 
no.  δ 
13C δ1H  HMBC 
1 123.1 -   8a 131.3 -  
2 105.9 7.23 (1H, s) 
C-3, C-4,  
C-10a, C-12 
9α 34.8 2.73 (1H, t,  
J = 13.8) 
C-8a, C-10, 
C-10a 
3 150.5 -   9β  3.49 (1H, dd,  
J = 13.8, 6.0) 
C-10a 
4 155.7 -  10 57.3 
4.60 (1H, dd,  
J = 13.8, 6.0) 
C-10a 
4a 123.8 -  10a 
134.
4 
-  
4b 135.1 -  12 
167.
9 
-  
5 127.7 
8.35 (1H, dd,  
J = 7.9, 1.4) 
C-4a, C-4b 3-OCH3 59.7 3.89 (3H, s) C-3 
6 127.9 
7.40 (1H, dd,  
J = 7.9, 1.4) 
C-7 4-OCH3 56.0 4.00 (3H, s) C-4 
7 130.0 
7.44 (1H, dd,  
J = 7.9, 1.4) 
C-6, C-8a N-OCH3 63.7 3.96 (3H, s)  
8 128.7 
7.35 (1H, dd,  
J = 7.9, 1.4) 
C-6, C-4b     
The 1H NMR spectrum of 5 also showed signals at δ 2.73 (H-9α, t, J = 13.8), δ 3.49 (H-9β, dd,  
J = 14.2, 6.0), δ 4.60 (H-10, dd, J = 13.8, 6.0), indicating that C-9 and C-10 are hydrogenated. To the 
knowledge of the authors, this is the first occurrence of a 9,10-dihydroaristolactam alkaloid. The  
13C-NMR spectrum (Table 4) showed the presence of eighteen carbons; three methyl, one methylene, 
six methine, seven quaternary and one carbonyl. The carbonyl carbon (C-12) resonated at δ 167.9. 
Thus, taking into consideration all the NMR data and analyses, the structure of tapisoidin (5) was 
elucidated as illustrated in Figure 1. Identification of the known compounds was done by comparison 
of 1H- and 13C-NMR data with reported values [13–18]. 
2.2. Bioactivity 
The result of cytotoxicity tests on the hexane, CH2Cl2 and MeOH crudes of G. tapisoides against 
lung cancer (A549), breast cancer (MCF-7) and prostate cancer (DU-145) cell lines are shown in  
Table 5. Hexane and CH2Cl2crude extractsexhibited cytotoxicity against the three cancer cell lines. 
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Table 5. Cytotoxicity of crude extracts from G. tapisoides against selected cancer cells at 100 µg/mL. 
Extracts 
Cell Viability (%) 
A549 MCF-7 DU-145 
Hexane 2.9 6.2 9.4 
CH2Cl2 2.9 6.4 8.3 
Methanol 87.2 94.8 82.3 
Among the isolated compounds, compounds 1–6 were evaluated for their cytotoxicity  
(Table 6). Onlycompound 6exhibited cytotoxic activity against all the eight cell lines. No cytotoxic 
activity was found for compounds 1–5, most probably due tolack of pharmacophoric groups 
responsible for the high antiproliferative activity [3]. 
Table 6. Biological activitiesof theisolated compounds (IC50, µM, mean ± s.d., n = 3). 
Cmpd. 
Antioxidant 
activity 
Cytotoxicity  
A549 1 DU-145 2 
SK-
MEL-5 3 
BxPC-3 4 Hep G2 5 HT-29 6 MCF-7 7 
MDA-
MB-231 8 
1 0.328 >150 >150 >150 >150 >150 >150 >150 >150 
2 0.207 >150 >150 >150 >150 >150 >150 >150 >150 
3 1.748 >150 >150 >150 >150 >150 >150 >150 >150 
4 0.252 >150 >150 >150 >150 >150 >150 >150 >150 
5 0.772 >150 >150 >150 >150 >150 >150 >150 >150 
6 2.024 
107.62 
± 4.67 
71.79  
± 1.61 
100.14 
± 11.84 
130.48 
± 7.69 
128.73 
± 1.81 
64.17  
± 5.60 
120.37  
± 11.11 
>150 
 
Cisplatin - 
37.37  
± 3.00 
15.18  
± 0.49 
31.82  
± 0.23 
20.10  
± 1.21 
22.07  
± 0.64 
77.24  
± 3.23 
91.49  
± 6.54 
276.53  
± 1.29 
Ascorbic 
acid 
0.075 - - - - - - - - 
1 human lung carcinoma; 2 human prostate carcinoma; 3skin cancer cell line; 4 human pancreatic carcinoma;  
5 human liver carcinoma; 6 human colon carcinoma; 7,8 human breast carcinomas. 
Compound 6isthe most potentagainstthe colon cancer cell line (HT-29). It exhibitedan IC50  
of 64.17 ± 5.60 µM, which is comparable to that of cisplatin (77.24 ± 3.23 µM). Therefore the 
cytotoxicity of both hexane and dichloromethane extracts may be attributed to the presence of 
compound6, which has been previously reported to exhibit cytotoxicity against variouscancer cell  
lines [13,19]. In addition, reports have shown that the antiproliferative activity of 6 is selective for 
cancer cell lines with no significant cytotoxicity toward non-malignant cells [13,20]. 
Since free radicals are associated with DNA damage and protein modifications, including apoptotic 
modulators which could lead to carcinogenesis [21], we have also evaluated the antioxidant activity 
using a DPPH radical scavenging assay. Compound 2 gave the highest antioxidant activity, with an 
IC50 of 0.207 µM, followed by compounds 4 (IC50 = 0.252 M) and 1 (IC50 = 0.328 M). The high 
antioxidant effect of compounds 2, 4 and 1 may be attributed to the presence of the hydroxyl group 
adjacent to the conjugated double bond that could donate electron to the DPPH free radical. Carotenes 
and xanthophyll which possess hydroxyl groups and conjugated double bonds have been reported to 
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show high antioxidant activity [22,23]. Compounds 3 (IC50 = 1.748 M), 5 (IC50 = 0.772 M) and 6 
(IC50 = 2.024 M) which lack hydroxyl groups in their structures showed very low antioxidant activity. 
3. Experimental  
3.1. General 
Melting points were determined by a Fargo MD-1D melting point apparatus. The specific rotations 
were measured on a Jasco P-1020 polarimeter. UV spectra were recorded on a Shimadzu 1650 PC 
ultraviolet-visible spectrometer, and IR spectra on a Perkin Elmer Spectrum 400 FT-IR/FT-FIR 
spectrometer. 1D and 2D NMR spectra were measured with a JEOL ECA 400 spectrometer  
(400 MHz). The mass spectra were obtained on an Agilent Technologies 6530 Accurate-Mass-Q-TOF 
LC/MS. Column chromatography was performed on silica gel Merck 60 (230-400 mesh). X-ray data 
collection was obtained from a BrukerAPEX2unit; cell refinement: SMART; data reduction: SAINT; 
program(s) used to solve the structure: SHELXTL; program(s) used to refine structure: SHELXTL. 
3.2. Plant Material 
The stem bark of G. tapisoides was collected from Sarawak and identified by Prof. Fasihuddin bin 
Ahmad, Faculty of Resource Science and Technology, Universiti Malaysia Sarawak. A voucher 
specimen (HUMS 000108) is deposited at the Herbarium of Universiti Malaysia Sarawak,  
Kota Samarahan, Sarawak, Malaysia. 
3.3. Extraction and Isolation 
The dried and milled stem barks of G. tapisoides (1.5 kg) were extracted successively with hexane, 
dichloromethane (CH2Cl2) and MeOH (15 L) to give 25 g of hexane extract, 43 g of CH2Cl2 extract 
and 24 g of MeOH extract, respectively, after removal of the solvents. The hexane extract (10 g) was 
subjected to silica gel column chromatography (CC), using hexane and CH2Cl2 with increasing 
polarity to give 6 (2.5 g). Then, the CH2Cl2 extract (20 g) was fractionated using CC with a gradient 
system of hexane/CH2Cl2 and CH2Cl2/MeOH to afford 11 fractions (F1-F11). F8 (CH2Cl2/MeOH, 
90:10) was separated on a column of silica gel using CH2Cl2/MeOH (97:3) as the eluent to give 1  
(12.3 mg). F9 (CH2Cl2/MeOH, 80:20) was further chromatographed on a silica gel column eluting with 
100% CH2Cl2 to give 2. F10 (CH2Cl2/MeOH, 50:50) was then purified by CC, using CH2Cl2/MeOH 
(99:1) to yield 3 (14.8 mg) and CH2Cl2/MeOH (96:4) to yield 4 (18.9 mg). F6 (CH2Cl2/MeOH, 98:2) 
was applied to a column of silica gel, eluted with CH2Cl2/MeOH (98:2) gave 5 (3.2 mg). F3 
(Hex/CH2Cl2, 50:50) was further purified by silica gel CC using hexane/CH2Cl2 (50:50) as eluting 
solvent to afford 6 (1.3 g). F6 was subjected to silica gel CC, using100% CH2Cl2 as eluent to yield 7 
(4.8 mg). F7 (CH2Cl2/MeOH, 95:5) was separated on column of silica gel usingCH2Cl2/MeOH (95:5) 
as developing solvent to yield 8 (1.1 g). Compounds 9 (1.2 mg), 10 (4.4 mg) and 11 (4.0 mg) were 
obtained from further purification of F6 (CH2Cl2/MeOH, 98:2) by CC using silica gel with a solvent 
system of CH2Cl2/MeOH (98:2). 
  
Molecules 2013, 18 137 
 
 
3.4. Cytotoxicity Assay 
Cytotoxicity of the compounds were evaluated against eight types of cancer cell lines; lung (A549), 
prostate (DU-145), skin (SK-MEL-5), pancreatic (BxPC-3), liver (Hep G2), colon (HT-29), breast 
cancer (MCF-7), and (MDA-MB-231). Cell lines were cultured in Dulbecco’s Modified Eagle medium 
(DMEM) with 10% foetal bovine serum. Cells were plated into 96-well microplates and 24 hour later, 
100 µL of samples and cisplatin standard were introduced in triplicate. Cells were further incubated for 
48 h and cell viability was determined using the MTS reagent (Promega Corp., Madison, WI, USA). 
Microplates were returned to the incubator for 1 h and absorbance was read on a microplate reader at 
490 nm (Infinite 200, Tecan, Männedorf, Swizerland). The concentration required causing 50% cell 
death (IC50) by the samples and drug standards were determined using dose-response curves in Prism 
5.02 software [24]. 
3.5. Antioxidant Assay 
The DPPH antioxidant assay was determined as described by Shimada et al. [25]. Briefly, 0.1 mM 
DPPH (1 mL) dissolved in ethanol was added to an ethanol solution (3 mL) of the tested compound at 
different concentrations (0, 50, 100, 150, 200 µg/mL). An equal volume of ethanol was added in the 
control test. The mixture was shaken vigorously and allowed to stand at room temperature for 30 min. 
Then the absorbance at 517 nm was measured with a UV–VIS spectrophotometer.  The percentage of 
scavenging of DPPH was calculated using the following equation: 
DPPH scavenging effect (%) = ஺°ି஺ଵ஺° ൈ 100 
where Ao is the absorbance of the control reaction and A1 is the absorbance in the presence of the sample. 
4. Conclusions 
The CH2Cl2 extract of the stem bark ofG. tapisoides yielded eleven compounds, of which five are 
new;goniomicins A-D(compounds 1–4), and tapisoidin (5). The latter, tapisoidin (5), represents the 
first report of the occurence of a 9,10-dihydroaristolactam alkaloid. From this study, the compound 
responsible for the cytotoxicity of the extracts is goniothalamin (6), which showed the highest potency 
against the colon cancer cell line (HT-29) withan IC50 of 64.17 ± 5.60 µM. Goniomicin A (1), 
goniomicin B (2) and goniomicin D (4) displayed high antioxidant activity, which may be due to the 
presence of conjugated hydroxyl groups that could donate electrons to scavenge radicals [22,23]. 
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Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/18/1/128/s1. 
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